300070.SZ
300070.SZ
CNE100000N95
BOW
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 42/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.39x
Defensive
Volatility (5Y p.a.)
32.3% p.a.
5-Year Horizon
Max Drawdown (5Y)
-58.7%
5-Year Horizon
Sharpe Ratio
-0.52
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -21.8%
3 Years 34.9% -49.8% -0.42 -12.2%
5 Years 32.3% -58.7% -0.52 -14.9%
10 Years 35.2% -86.0% -0.51 -15.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 57.3 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -86.0% in the extended horizon.
ende